New Hampshire bills · 2026 Regular Session
New Hampshire SB 477
relative to increasing transparency in the 340B Drug Pricing Program.
- Introduced
- In committee
- Passed Senate
- Passed House
- To Governor
- Became law
Sponsors
- Tim McGough (Republican)
Cosponsors (9)
- Katelyn Kuttab (Republican)
- Brian Cole (Republican)
- Keith Ammon (Republican)
- Wayne MacDonald (Republican)
- Julie Miles (Republican)
- Daniel Innis
- Regina Birdsell (Republican)
- Howard Pearl (Republican)
- Bill Gannon (Republican)
Summary
No official summary is available for this bill.
Latest action(Mar 5, 2026): Refer to Interim Study, MA, VV; 03/05/2026; SJ 5
Text versions
Roll-call votes
No recorded votes on this bill.
Actions
- Mar 5, 2026 · Senate
Refer to Interim Study, MA, VV; 03/05/2026; SJ 5 - Feb 19, 2026 · Senate
Committee Report: Referred to Interim Study, 03/05/2026, Vote 5-0; SC 8 - Feb 19, 2026 · Senate
Special Order to the Next Session, Without Objection, MA; 02/19/2026; SJ 4 - Feb 19, 2026 · Senate
SB 477 was Removed from the Consent Calendar; 02/19/2026; SJ 4 - Feb 12, 2026 · Senate
Committee Report: Referred to Interim Study, 02/19/2026; Vote 5-0; CC; SC 6 - Jan 12, 2026 · Senate
Hearing: 01/21/2026, Room 100, SH, 01:30 pm; SC 2 - Nov 21, 2025 · Senate
Introduced 01/07/2026 and Referred to Health and Human Services; SJ 1